Tristan Ide

Mr. Tristan Ide


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 September 2024 in Preprints.org
Verified
Preprint
Open access
PDF file
TITristan Ide
Tristan Ide
JEJosh Erched
Josh Erched
CSCaroline Schafer
Caroline Schafer
KCKaren Chuchuca
Karen Chuchuca
Catalog and key for identifying common marine invertebrates in the Little Sippewissett Marsh, Woods Hole, MA. Species identifications from August to September 2024 focused on arthropoda phylum and interacting ecosystems.

23 July 2024 in Preprints.org
Verified
Preprint
Open access
PDF file
HZHannah J. Zhang
Hannah J. Zhang
TITristan Ide
Tristan Ide
MSM Siva
M Siva
LLLara Leoni
Lara Leoni
Jeffrey S. SourisJeffrey S. Souris
Jeffrey S. Souris
CCChin-Tu Chen
Chin-Tu Chen
Traditional photodynamic therapy (PDT) is often limited in its efficacy by insufficient light penetration, inefficient photosensitizer energy transfer, and inadequate target tissue oxygena tion. X-ray activated PDT (XPDT), using nanoparticle (NPs) photosensitizers comprised of euro pium-doped yttrium oxide cores encased within silica shells (Y2O3:Eu@SiO2), offers the potential of overcoming most of these limitations. Aimed at maximizing the generation of reactive oxygen spe cies (ROS), this study reports methodologies for investigation of the effects of synthesis conditions on the characteristics of Y2O3:Eu@SiO2 NP. Transmission electronic microscope (TEM) revealed that the NP core diameter was linearly, positively correlated with condensation time (R 2 = 0.7357, p < 0.05) and linearly, negatively correlated with urea concentration (R 2 = 0.958, p < 0.05). The addition of cetyltrimethylammonium bromide (CTAB) during core synthesis demonstrated enhanced parti cle dispersion. Silica coating via APTES-1 and TEOS-3 conditions resulted in Y2O3:Eu@SiO2 NPs that generated the highest ROS, with 8.7-fold and 8.9-fold increase respectively in relative fluorescence intensity at 8 Gy irradiation compared to a 5.2-fold increase in PBS under the same condition. In vivo evaluation using 18 F-fluorothymidine positron emission tomography ( 18 F-FLT PET) of mouse xeno grafts of a human prototypical cancer (ovarian) revealed a 55% reduction in tumor proliferation of radiation-sensitive CAOV3 tumors treated with Y2O3:Eu@SiO2 NPs compared to a 19% reduction in tumor proliferation of radiation-resistant SKOV3 tumors on the fourth day post-treatment. Taken together, these findings suggest Y2O3:Eu@SiO2 NPs can serve as effective photosensitizers for XPDT and their performance characteristics can be optimized by selecting synthesis conditions and param eters to deliver the desirable therapeutic effects, offering novel approaches to circumventing many of the limitations of conventional PDT in the treatment of cancer.